Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IM Cannabis Corp C.IMCC

Alternate Symbol(s):  IMCC

IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The Company operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The Company operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.


CSE:IMCC - Post by User

Comment by TheBridgeon Nov 15, 2021 10:51am
131 Views
Post# 34127094

RE:RE:Good Numbers

RE:RE:Good NumbersLet's get realistic here. You're absolutely right, the share price is a joke right now. After these financials it clearly evident that it's got a long ways to go and will take a significant amount of time to get there. It appears that the glossy "good numbers" overlooked or ignored other aspects of the financial statement. I noted the improvements that they have made but I also noted the rest of their results which included:
BASIC INCOME (Loss) per common share for Q3 was $(0.06) compared to $0.004 in Q3 2020. DILUTED INCOME (Loss) per common share for the Q3 2021 was $(0.18) compared to $0.004 in Q3 2020. NET LOSS for Q3 2021 was $(5.7) million. And on Oct. 15, 2021 IMC made its 3rd. of 5 installments of shares in connection with Panaxia Transaction. These installments continue to dilute the share numbers.
Now do these factors scream that the share price is a joke? Possibly if you're inferring that the share price is too high. These are not the financial numbers yet that one would be getting excited over and leaping in with both feet. Marvin K. Mooney says that the time is still not now.
<< Previous
Bullboard Posts
Next >>